The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
The urokinase receptor is required for human monocyte chemotaxis in vitro.
Open accessAbstract
Mononuclear phagocytes (Mphi) produce urokinase-type plasminogen activator (uPA) and also express a specific cell-surface receptor for urokinase, uPAR. The concomitant expression of these proteins provides a mechanism by which Mphi can degrade extracellular matrix proteins during directed cell migration. In this study, we sought to determine if uPAR plays a role in Mphi chemotaxis that is distinct from its role in matrix proteolysis. Exposing adherent monocytes to a chemotactic gradient causes plasma membrane uPAR to localize strongly to the leading edge of cell migration. Adherence alone or exposure to FMLP had no effect on uPAR expression. Using Boyden chamber chemotaxis assays, we demonstrate that treating mononuclear cells with an anti-uPAR mAb (either as an intact mAb or F[ab']2) ablates chemotaxis induced by FMLP and monocyte chemotactic peptide-1 (P < 0.001). Inactivating the catalytic activity of uPAR-bound uPA had no effect on chemotaxis. Similarly, blocking uPAR expression with an antisense oligonucleotide to uPAR completely ablates chemotaxis, but blocking uPA expression with an antisense oligonucleotide to uPA has a minimal effect. We therefore demonstrate that expression and unimpeded function of uPAR plays an obligate role in M phi chemotaxis by mechanisms that are largely independent of its ligand, uPA. Combined with its known role in mediating pericellular proteolysis, these observations demonstrate that uPAR is essential for both locomotion and traversing tissue barriers during M phi migration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Baltosser, W. H., & Zar, J. H. (1996) · Ecology · doi:10.2307/2265725 · Cited by 35,166
Zar, J. H. (1996) · Cited by 7,837
Plasminogen Activators, Tissue Degradation, and Cancer
(1985) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60028-7 · Cited by 2,535
Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130
Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T., Hirano, T., & Kishimoto, T. (1989) · Cell · doi:10.1016/0092-8674(89)90438-8 · Cited by 1,396
The plasminogen activator/plasmin system.
Vassalli, J. D., Sappino, A. P., & Belin, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115405 · Cited by 1,164
Molecular cloning and expression of an IL-6 signal transducer, gp130
Hibi, M., Murakami, M., Saito, M., Hirano, T., Taga, T., & Kishimoto, T. (1990) · Cell · doi:10.1016/0092-8674(90)90411-7 · Cited by 1,039
On the Crawling of Animal Cells
Stossel, T. P. (1993) · Science · doi:10.1126/science.8493552 · Cited by 1,011
GPI-Anchored Cell-Surface Molecules Complexed to Protein Tyrosine Kinases
Štefanová, I., Hořejši, V., Ansotegui, I. J., Knapp, W., & Stockinger, H. (1991) · Science · doi:10.1126/science.1719635 · Cited by 826
Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines.
Miller, M. D., & Krangel, M. S. (1992) · PubMed · Cited by 731
Roldan, A. L., Cubellis, M. V., Masucci, M. T., Behrendt, N., Lund, L. R., Danø, K., Appella, E., & Blasi, F. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08132.x · Cited by 603
The Receptor for Ciliary Neurotrophic Factor
Davis, S., Aldrich, T. H., Valenzuela, D. M., Wong, V., Furth, M. E., Squinto, S. P., & Yancopoulos, G. D. (1991) · Science · doi:10.1126/science.1648265 · Cited by 603
Liotta, L. A., Goldfarb, R. H., Brundage, R. A., Siegal, G. P., Terranova, V. P., & Garbisa, S. (1981) · PubMed · Cited by 598
Naldini, L., Tamagnone, L., Vigna, E., Sachs, M., Hartmann, G., Birchmeier, W., Daikuhara, Y., Tsubouchi, H., Blasi, F., & Comoglio, P. M. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05588.x · Cited by 565
Saksela, O., & Rifkin, D. B. (1990) · The Journal of cell biology · doi:10.1083/jcb.110.3.767 · Cited by 539
Immune mechanisms in atherosclerosis.
Hansson, G. K., Jonasson, L., Seifert, P. S., & Stemme, S. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.5.567 · Cited by 515
Estreicher, A., Mühlhauser, J., Carpentier, J. L., Orci, L., & Vassalli, J. D. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.2.783 · Cited by 469
Vassalli, J. D., Dayer, J. M., Wohlwend, A., & Belin, D. (1984) · The Journal of experimental medicine · doi:10.1084/jem.159.6.1653 · Cited by 401
Moscatelli, D., & Rifkin, D. B. (1988) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(88)90005-4 · Cited by 352
Upregulation of urokinase receptor expression on migrating endothelial cells
Pepper, M., Sappino, A., Stöcklin, R., Montesano, R., Orci, L., & Vassalli, J. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.3.673 · Cited by 270
Immune mechanisms in atherosclerosis.
KHansson, G., LJonasson, SSeifert, P., & SStemme (1989) · Arteriosclerosis An Official Journal of the American Heart Association Inc · Cited by 244
Structural requirements for the growth factor activity of the amino-terminal domain of urokinase.
Rabbani, S. A., Mazar, A. P., Bernier, S. M., Haq, M., Bolivar, I., Henkin, J., & Goltzman, D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49691-9 · Cited by 234
Bingham, H. G. (1982) · Plastic and Reconstructive Surgery · doi:10.1097/00006534-198206000-00105 · Cited by 227
Chapman Jr., H. A., Vavrin, Z., & Hibbs Jr., J. B. (1982) · Cell · doi:10.1016/0092-8674(82)90220-3 · Cited by 219
The human urokinase-plasminogen activator gene and its promoter
Riccio, A., Grimaldi, G., Verde, P., Sebastio, G., Boast, S., & Blasi, F. (1985) · Nucleic Acids Research · doi:10.1093/nar/13.8.2759 · Cited by 207
Huber, A. R., & Weiss, S. J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113992 · Cited by 184
Juliano, R. L. (1987) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(87)90009-6 · Cited by 179
Ossowski, L., Russo-Payne, H., & Wilson, E. L. (1991) · PubMed · Cited by 178
Chapman, H. A., Stone, O. L., & Vavrin, Z. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111275 · Cited by 166
Proteolytic processing of the 72,000-Da type IV collagenase by urokinase plasminogen activator
Keski‐Oja, J., Lohi, J., Tuuttila, A., Tryggvason, K., & VARTIO, T. (1992) · Experimental Cell Research · doi:10.1016/0014-4827(92)90101-d · Cited by 150
An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines.
Nusrat, A., & Chapman, H. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115070 · Cited by 140
Vascular cell interactions with special reference to the pathogenesis of atherosclerosis.
Pf, D. (1986) · PubMed · Cited by 138
Proliferation of a human epidermal tumor cell line stimulated by urokinase
Kirchheimer, J. C., Wojta, J., Christ, G., & Binder, B. R. (1987) · The FASEB Journal · doi:10.1096/fasebj.1.2.3038646 · Cited by 129
Saksela, O., Hovi, T., & Vaheri, A. I. (1985) · Journal of Cellular Physiology · doi:10.1002/jcp.1041220119 · Cited by 125
Single chain urokinase. Augmentation of enzymatic activity upon binding to monocytes
Manchanda, N., & Schwartz, B. S. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98725-9 · Cited by 107
Plasmin degradation of cartilage proteoglycan
Mochan, E., & Keler, T. (1984) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(84)90412-4 · Cited by 97
Dumler, I., Petri, T., & Schleuning, W.-D. D. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81106-a · Cited by 95
Min, H. Y., Semnani, R. T., Mizukami, I. F., Watt, K. W. K., Todd, R. F., & Liu, D. Y. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.11.3636 · Cited by 90
Self-citationPlasminogen activator inhibitor type I stabilizes vitronectin-dependent adhesions in HT-1080 cells.
Ciambrone, G. J., & McKeown‐Longo, P. J. (1990) · The Journal of Cell Biology · doi:10.1083/jcb.111.5.2183 · Cited by 77
Receptor-receptor interactions of complement receptor type 3 in neutrophil membranes
Petty, H. R., & Todd, R. R. (1993) · Journal of Leukocyte Biology · doi:10.1002/jlb.54.5.492 · Cited by 66
Self-citationModels For Receptor-Mediated Cell Phenomena: Adhesion And Migration
Lauffenburger, D. A. (1991) · Annual Review of Biophysics and Biophysical Chemistry · doi:10.1146/annurev.bb.20.060191.002131 · Cited by 47
Mizukami, I. F., Vinjamuri, S. D., Trochelman, R. D., & Todd, R. F. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.5.1841 · Cited by 26
Self-citation
Cited by
The urokinase-type plasminogen activator system in cancer metastasis: A review
Andreasen, P. A., Kjøller, L., Christensen, L., & Duffy, M. J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970703)72:1<1::aid-ijc1>3.0.co;2-z · Cited by 1,546
uPAR: a versatile signalling orchestrator
Blasi, F., & Carmeliet, P. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm977 · Cited by 1,223
Regulation of cell signalling by uPAR
Smith, H. W., & Marshall, C. J. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2821 · Cited by 960
The plasminogen activation system in tumor growth, invasion, and metastasis
Andreasen, P. A., Egelund, R., & Petersen, H. H. (2000) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180050497 · Cited by 943
Matrix metalloproteinases in tumor invasion and metastasis
Stamenkovic, I. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0379 · Cited by 815
Metadata
- Authors
- Gyetko, M. R., Todd, R. F., Wilkinson, C. C., & Sitrin, R. G.
- Venue
- Journal of Clinical Investigation
- Published
- 1994-04-01
- Volume
- 93
- Issue
- 4
- Pages
- 1380-1387
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2002387352
- Cited by
- 298
- References
- 41
- FWCI
- 11.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.